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Filaggrin polymorphism P478S,  
IgE level, and atopic phenotypes
Wang et al. report that filaggrin (FLG) P478S polymorphism may 
confer susceptibility to the development of atopic dermatitis 
(AD) among Chinese individuals and predispose subjects with 
AD later to develop asthma and allergic rhinitis. FLG P478S GG 
genotype was significantly related to AD in children with IgE 
level ≥ 100 kU L−1 but the association was not evident when IgE 
level was < 100 kU L−1. As the adverse effects of allergen expo-
sures were largely restricted to children carrying FLG P478S 
GG genotype, it is suggested that preventive measures to avoid 
allergens or early interventions using topical emollients should 
be introduced in these susceptible children to avoid subsequent 
sensitization. Br J Dermatol 2011; 164: 791–6.
Noninvasive genomic detection of melanoma
Wachsman et al. harvested the skin overlying pigmented 
lesions using epidermal genetic information retrieval (EGIRTM). 
RNA isolated from the tapes was amplified and gene expres-
sion profiled. All lesions were removed for histopathological 
evaluation. Three hundred and twelve genes were identified 
that are differentially expressed between melanoma, naevi and 
normal skin. Subsequent class prediction modelling of a train-
ing dataset, consisting of 37 melanomas and 37 naevi, iden-
tified a 17-gene classifier. This classifier had 100% sensitivity 
and 88% specificity for the detection of in situ and invasive 
superficial spreading melanoma, lentigo maligna and lentigo 
maligna melanoma. It also discriminated melanoma from basal 
cell carcinoma, solar lentigo and normal skin. These results 
demonstrate that EGIR-harvested specimens can be used to 
detect melanoma accurately by means of a 17-gene genomic 
biomarker. Br J Dermatol 2011; 164: 797–806.
Parental sun-protective regimens and prevalence 
of common melanocytic naevi among 7-year-old 
children in Sweden: changes over a 5-year period
Results of this population-based study showed that over 
a 5-year period, more active sun protection and fewer 
melanocytic naevi were demonstrated among Swedish 
children. Results support the use of melanocytic naevi 
as an objective measure of sun exposure in children. Br J 
Dermatol 2011; 164: 830–7.
Fumarates vs. methotrexate  
in moderate to severe chronic plaque 
psoriasis: a multicentre prospective 
randomized controlled clinical trial
Sixty patients with moderate to severe psoriasis vulgaris 
were randomly assigned to treatment for 16 weeks with 
either methotrexate or fumarates and were followed up 
for another 4 weeks. Methotrexate and fumarates were 
found to be equally effective in the treatment of patients 
with moderate to severe psoriasis. No serious or irrevers-
ible adverse events were observed in any of the patients. 
Br J Dermatol 2011; 164: 855–61.
Cardiovascular safety  
of ustekinumab in patients  
with moderate to severe psoriasis:  
results of integrated analyses of data  
from phase II and III clinical studies
This report provides a detailed assessment of major 
adverse cardiovascular (CV) events [myocardial infarction 
(MI), stroke or CV death] based on pooled analyses of 
phase II⁄III trials in 3117 patients treated with usteki-
numab. Standardized incidence ratios for comparison 
of ustekinumab clinical data with external data sources 
ranged from 0.34 to 0.52, suggesting no increased risk of 
MI or stroke in ustekinumab-treated patients compared 
with the general U.S. and psoriasis populations. Available 
clinical data suggest neither a detrimental nor a beneficial 
effect of ustekinumab on serious CV events. Additional 
data are needed to clarify the effect of ustekinumab on 
CV events. Br J Dermatol 2011; 164: 862–72.
